Filter News

News By Country

None Found

News By Tag

October 2026
We	Tu	Mo	Su	Sa	Fr	Th
14	13	12	11	10	9	8

Public Company News

Business Press Releases

Pharmacy Benefits Press Releases

Topics Locations Industries Dates

Cost Plus Drugs and Oread Rx to Launch OTULFI™, an Affordable STELARA® Biosimilar, in April 2025

By Oread Rx

Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), and Oread Rx, LLC, announce a relationship to supply OTULFI™, a biosimilar of STELARA® to customers in April 2025.

Page updated every 10 minutes

Trending

Congress Leaders G.V. Harsha Kumar and Bhakta Charan Das Meet in Delhi

Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources

Beyond Wealth and Recognition: Caribbean Author Lyndon Alexander Hall Redefines Success

The Vascular Care Group's Lowell Office Welcomes Dr. Sahil Mehta, Prostate Artery Embolization Specialist

Ironrock Commercial Construction Highlights Industry-Leading Commercial Construction Services Across Orlando and Central Florida